Paychex, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment
Paychex, Inc. (PAYX) reported Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment of $0 for the 9-month period ending 2024-02-29, per its 10-Q filed 2024-04-02.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment · last filed 2024-04-02
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for the quarter ending 2024-02-29 was $0.00.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for the quarter ending 2023-11-30 was $0.00.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for the quarter ending 2023-08-31 was $0.00, a 100.00% decline year-over-year.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for the quarter ending 2023-05-31 was -$9.90M, a 10000.00% decline year-over-year.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for fiscal 2023 was -$9.80M, a 5000.00% decline from fiscal 2022.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for fiscal 2022 was $200.00K, a 83.33% decline from fiscal 2021.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for fiscal 2021 was $1.20M, a 89.38% decline from fiscal 2020.
- Paychex, Inc. debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment for fiscal 2020 was $11.30M.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment 12 month |
|---|---|---|---|---|
| 2024-02-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-02 | $0.00 derived: sum of 2 quarters · filed 2024-04-02 | $0.00 10-Q · filed 2024-04-02 | -$9.90M derived: sum of 4 quarters · filed 2024-04-02 |
| 2023-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-21 | $0.00 10-Q · filed 2023-12-21 | -$9.90M derived: sum of 3 quarters · filed 2023-12-21 | -$9.90M derived: sum of 4 quarters · filed 2024-04-02 |
| 2023-08-31 | $0.00 10-Q · filed 2023-09-28 | -$9.90M derived: sum of 2 quarters · filed 2023-09-28 | -$9.90M derived: sum of 3 quarters · filed 2024-04-02 | -$9.90M derived: sum of 4 quarters · filed 2024-04-02 |
| 2023-05-31 | -$9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | -$9.90M derived: sum of 2 quarters · filed 2024-04-02 | -$9.90M derived: sum of 3 quarters · filed 2024-04-02 | -$9.80M 10-K · filed 2023-07-14 |
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-02 | $0.00 derived: sum of 2 quarters · filed 2024-04-02 | $100.00K 10-Q · filed 2024-04-02 | $200.00K derived: sum of 4 quarters · filed 2024-04-02 |
| 2022-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-21 | $100.00K 10-Q · filed 2023-12-21 | $200.00K derived: sum of 3 quarters · filed 2023-12-21 | $200.00K derived: sum of 4 quarters · filed 2023-12-21 |
| 2022-08-31 | $100.00K 10-Q · filed 2023-09-28 | $200.00K derived: sum of 2 quarters · filed 2023-09-28 | $200.00K derived: sum of 3 quarters · filed 2023-09-28 | $200.00K derived: sum of 4 quarters · filed 2023-09-28 |
| 2022-05-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $100.00K derived: sum of 2 quarters · filed 2023-07-14 | $100.00K derived: sum of 3 quarters · filed 2023-07-14 | $200.00K 10-K · filed 2023-07-14 |
| 2022-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $100.00K 10-Q · filed 2023-03-30 | $300.00K derived: sum of 4 quarters · filed 2023-07-14 |
| 2021-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-22 | $100.00K 10-Q · filed 2022-12-22 | $300.00K derived: sum of 3 quarters · filed 2023-07-14 | $600.00K derived: sum of 4 quarters · filed 2023-07-14 |
| 2021-08-31 | $100.00K 10-Q · filed 2022-09-29 | $300.00K derived: sum of 2 quarters · filed 2023-07-14 | $600.00K derived: sum of 3 quarters · filed 2023-07-14 | |
| 2021-05-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $500.00K derived: sum of 2 quarters · filed 2023-07-14 | $1.20M 10-K · filed 2023-07-14 | |
| 2021-02-28 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-31 | $1.00M 10-Q · filed 2022-03-31 | ||
| 2020-11-30 | $700.00K 10-Q · filed 2021-12-22 | |||
| 2020-05-31 | $11.30M 10-K · filed 2022-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FORRESTER RESEARCH, INC. (FORR) | United States | $0.220B | -3.81 |